Adaptin Bio (APTN) Assets Average (2023 - 2026)

Adaptin Bio's Assets Average history runs 4 years deep, the most recent figure standing at $662638.0 for Q1 2026.

• In Q1 2026, Assets Average fell 57.16% year-over-year to $662638.0; the TTM figure through Mar 2026 stood at $662638.0 (down 57.16% YoY), while the FY2025 annual figure was $429287.0, up 258.04% from the prior year.
• Assets Average came in at $662638.0 for Q1 2026 at Adaptin Bio, down from $799316.5 in the prior quarter.
• In the past five years, Assets Average ranged from a high of $2.3 million in Q2 2025 to a low of $322.0 in Q3 2024.
• A 4-year average of $670934.0 and a median of $391253.2 in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average soared 643295.87% in 2025 and tumbled 57.16% in 2026, its largest moves.
• Adaptin Bio's Assets Average stood at $380.0 in 2023, then soared by 31444.34% to $119868.5 in 2024, then jumped by 566.83% to $799316.5 in 2025, then declined by 17.1% to $662638.0 in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $662638.0, $799316.5, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison